Interested in Joining a Registry?
Gain Procedural Treatment Insights on Patients with Uncontrolled Hypertension
Renal denervation (RDN) is emerging as an important therapy option for patients with uncontrolled or treatment resistant hypertension. As facilities, clinicians and researchers prepare for broader adoption, the need for consistent, high quality real world data has never been greater.
The NCDR Renal Denervation Module gives participating facilities a national platform to collect, evaluate and report data on renal denervation procedures. By capturing key procedural, safety, efficacy and long-term outcome information, the module supports data-driven quality improvement and helps advance the future of hypertension care.
Already participating in the CathPCI Registry?
Expand your NCDR footprint and receive discounted access to the Renal Denervation Module.
Why Participate
By gaining actionable clinical and operational insights through NCDR data collection and reporting, participating teams can better understand real-world RDN use and identify opportunities to improve care delivery. The Renal Denervation Module's performance dashboards will help clinical teams:
- Optimize patient selection
- Understand the impact of RDN on blood pressure outcomes
- Ensure appropriate medication management
- Monitor length of stay (LOS)
If your facility is not yet enrolled, submit a Request for Information to connect with our team about eligibility, timelines, and next steps.
For general data collection questions or support, please Contact Us.
